Your browser is no longer supported. Please, upgrade your browser.
MCK McKesson Corporation monthly Stock Chart
MCK [NYSE]
McKesson Corporation
IndexS&P 500 P/E6.93 EPS (ttm)23.89 Insider Own0.29% Shs Outstand216.29M Perf Week1.01%
Market Cap35.81B Forward P/E12.79 EPS next Y12.94 Insider Trans-29.24% Shs Float210.18M Perf Month4.13%
Income5.19B PEG1.93 EPS next Q2.89 Inst Own89.50% Short Float1.88% Perf Quarter13.54%
Sales198.53B P/S0.18 EPS this Y137.00% Inst Trans0.50% Short Ratio2.29 Perf Half Y17.32%
Book/sh52.33 P/B3.16 EPS next Y6.61% ROA8.60% Target Price166.64 Perf Year-8.79%
Cash/sh12.87 P/C12.87 EPS next 5Y3.59% ROE54.10% 52W Range114.53 - 199.43 Perf YTD17.89%
Dividend1.12 P/FCF9.11 EPS past 5Y33.50% ROI27.90% 52W High-16.98% Beta1.12
Dividend %0.68% Quick Ratio0.60 Sales past 5Y10.20% Gross Margin5.70% 52W Low44.56% ATR3.33
Employees78000 Current Ratio1.00 Sales Q/Q4.40% Oper. Margin3.60% RSI (14)66.76 Volatility2.14% 1.76%
OptionableYes Debt/Eq0.77 EPS Q/Q751.10% Profit Margin2.60% Rel Volume1.02 Prev Close162.87
ShortableYes LT Debt/Eq0.66 EarningsMay 18 AMC Payout4.80% Avg Volume1.72M Price165.57
Recom2.70 SMA201.79% SMA5010.10% SMA20010.43% Volume1,753,962 Change1.66%
May-30-17Reiterated Mizuho Neutral $147 → $168
May-23-17Upgrade JP Morgan Neutral → Overweight
May-19-17Reiterated UBS Neutral $145 → $156
May-17-17Resumed Jefferies Hold $153
Apr-04-17Initiated Needham Hold
Jan-18-17Upgrade Avondale Mkt Perform → Mkt Outperform
Jan-05-17Downgrade JP Morgan Overweight → Neutral $169
Jan-03-17Downgrade Mizuho Buy → Neutral $147
Nov-23-16Downgrade Credit Suisse Neutral → Underperform
Nov-11-16Downgrade Standpoint Research Buy → Hold
Nov-09-16Upgrade Mizuho Neutral → Buy $147
Oct-28-16Upgrade Standpoint Research Hold → Buy
Oct-28-16Downgrade Robert W. Baird Outperform → Neutral $200 → $164
Oct-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Oct-28-16Downgrade Deutsche Bank Buy → Hold $196 → $153
Sep-26-16Reiterated Mizuho Neutral $197 → $183
Sep-16-16Downgrade Goldman Buy → Neutral
Aug-11-16Reiterated Mizuho Neutral $174 → $197
Jun-07-16Resumed BofA/Merrill Neutral
Jun-07-16Reiterated Mizuho Neutral $164 → $174
Jun-22-17 09:46AM  Should Value Investors Consider McKesson (MCK) Stock? Zacks
Jun-21-17 04:24PM  McKesson Corporation to Webcast Investor Day Business Wire
Jun-20-17 09:45PM  U.S. Supreme Court ruling threatens massive talc litigation against J&J Reuters
01:24PM  Gender diversity on Fortune 500 boards just took a step backward Yahoo Finance
08:04AM  Should Investors Steer Clear of Opioid Drug Stocks? Motley Fool
Jun-19-17 11:50AM  Here are the 10 highest-paid Bay Area CEOs over the past five years American City Business Journals
04:01AM  Why Is McKesson (MCK) Up 13% Since the Last Earnings Report? Zacks
Jun-14-17 05:00AM  Opioid Costs Push Struggling States to Dust Off Tobacco Strategy Bloomberg
Jun-13-17 11:23AM  Following the Pills: Inside the Governments Investigation of McKesson Fortune
06:30AM  As Americas Opioid Crisis Spirals, Giant Drug Distributor McKesson Is Feeling the Pain Fortune
Jun-08-17 01:29PM  McKesson CEO slashes price on Orinda home by $6 million after a year on the market American City Business Journals
08:15AM  Earnings Highlights and Review: McKesson's Quarterly Revenue Grew 4%; Adjusted EPS Climbed 8% Accesswire
Jun-06-17 07:14AM  Here's What Drove McKesson Corporation Stock Up 18% in May Motley Fool
Jun-05-17 02:30PM  ETFs with exposure to McKesson Corp. : June 5, 2017 Capital Cube
Jun-02-17 12:16PM  McKesson Corp. : MCK-US: Dividend Analysis : June 05th, 2017 (record date) : By the numbers : June 2, 2017 Capital Cube
May-31-17 12:35PM  Primary Detractor in the U.S. Moat Indexs Performance in April Market Realist
12:28PM  Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic CNBC
May-30-17 09:15AM  Analysts' Actions -- Ambarella, BlackBerry, PVH Corp., Zynga and More TheStreet.com
May-27-17 12:47AM  [$$] McKesson's Comeback Should Continue Barrons.com
May-26-17 01:16PM  ETFs with exposure to McKesson Corp. : May 26, 2017 Capital Cube
May-25-17 04:10PM  McKesson Corporation to Present at the Goldman Sachs 38th Annual Global Healthcare Conference Business Wire
08:43AM  McKesson Corp. :MCK-US: Earnings Analysis: Q4, 2017 By the Numbers : May 25, 2017 Capital Cube
May-24-17 11:00PM  Edited Transcript of MCK earnings conference call or presentation 18-May-17 9:00pm GMT Thomson Reuters StreetEvents
04:10PM  McKesson Declares Quarterly Dividend May 24, 2017 Business Wire
May-23-17 10:11AM  McKesson Upgraded at JPMorgan TheStreet.com
08:02AM  McKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : May 23, 2017 Capital Cube
May-22-17 05:01PM  Spike In McKesson Prompts Vetr Downgrade To Hold Benzinga
01:00PM  These Stocks Are Changing Direction TheStreet.com
May-19-17 05:00PM  US stocks close broadly higher; oil rises Associated Press +8.18%
04:31PM  Why Dynegy, McKesson, and Deere Jumped Today Motley Fool
12:34PM  Here's Why McKesson Corporation Stock Is Climbing Today Motley Fool
09:47AM  McKesson (MCK) Beats Earnings Estimate in Q4, Revenues Miss Zacks
07:45AM  Early movers: DE, FL, CPB, GPS, SYF, CRM & more CNBC
May-18-17 07:53PM  McKesson Finishes a Tough Fiscal Year With Solid Momentum Motley Fool
05:26PM  McKesson Shares Jump After Fourth Quarter Beat TheStreet.com
04:58PM  Drug distributor McKesson's profit beats, shares jump Reuters
04:56PM  After-hours buzz: CRM, GPS, MCK & more CNBC
04:36PM  McKesson beats 4Q profit forecasts Associated Press
04:28PM  McKesson shares surge after earnings, outlook top Street view MarketWatch
04:20PM  Drug distributor McKesson's quarterly revenue rises 4.4 pct Reuters
04:10PM  McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results Business Wire
May-17-17 05:48PM  Eyes Are on McKesson's Guidance TheStreet.com
09:52AM  Hold on Concert's Hair Loss Trials Pushes Shares Down 10% TheStreet.com
May-15-17 05:19PM  McKesson Corp. Value Analysis (NYSE:MCK) : May 15, 2017 Capital Cube
May-12-17 08:58AM  McKesson (MCK) Q4 Earnings: Will the Stock Disappoint? Zacks
08:05AM  McKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : May 12, 2017 Capital Cube
May-04-17 11:42AM  Cost controls help drug wholesaler AmerisourceBergen's profit beat Reuters
May-02-17 04:40PM  What's the Next Berkshire Hathaway Acquisition? GuruFocus.com
May-01-17 10:47AM  McKesson: Bears Still Have the Upper Hand TheStreet.com
Apr-29-17 03:15AM  Arkansas will face challenges replenishing execution supply Associated Press
Apr-27-17 06:02PM  These are the only 9 stocks Morningstar is fully bullish on MarketWatch
Apr-26-17 08:28PM  There are only nine five-star U.S. stocks, but dont panic: Morningstar CEO MarketWatch
Apr-25-17 04:47PM  Jerome Dodson Keeps Buying McKesson, Axalta, Pentair GuruFocus.com
Apr-21-17 03:09PM  Drugmaker asked Arkansas not to use drug in executions Associated Press
12:29PM  Arkansas conducts first execution since 2005, plans 3 more Associated Press
07:11AM  Arkansas conducts first execution since 2005, plans 3 more Associated Press
03:01AM  Arkansas overcomes legal hurdles, carries out execution Associated Press
01:36AM  Arkansas executes first inmate in 12 years Reuters
01:11AM  Arkansas carries out first execution since 2005 Associated Press
Apr-20-17 07:14PM  Arkansas court allows execution drug hours ahead of lethal injection Reuters
05:53PM  Cherokee Nation sues opioid wholesalers, retailers for abuse Associated Press
04:10PM  McKesson Corporation Fiscal 2017 Fourth Quarter Conference Call Scheduled for May 18, 2017 Business Wire
12:59AM  The Latest: Arkansas governor disappointed by court ruling Associated Press
Apr-19-17 11:13PM  Arkansas suffers 2 setbacks to multiple execution plan Associated Press
10:01PM  The Latest: Arkansas governor disappointed by court ruling Associated Press
07:19PM  Arkansas court blocks 1 execution set for Thursday Associated Press
01:09AM  [$$] Cardinal Healths $6.1 Billion Deal for Some Medtronic Operations Raises Debt Concerns The Wall Street Journal
Apr-18-17 10:19PM  Company sues Arkansas, charging fraud over lethal injection drugs Reuters
07:13PM  Company sues Arkansas, charging fraud over lethal injection drugs Reuters
11:25AM  [$$] Cardinal Health to Buy Medtronic Businesses for $6.1 Billion The Wall Street Journal
02:17AM  US Supreme Court spares Arkansas inmate from execution Associated Press
02:17AM  US Supreme Court spares Arkansas inmate from execution Associated Press
Apr-17-17 08:43PM  The makers of a lethal-injection drug have become leaders in Arkansas' death-penalty battle Business Insider
Apr-15-17 06:23PM  Judge halts Arkansas plan to execute 8 inmates in 11 days Associated Press
01:48PM  Judge halts Arkansas plan to execute 8 inmates in 11 days Associated Press
12:03AM  Arkansas' multiple execution plan appearing to unravel Associated Press
Apr-14-17 09:19PM  Arkansas' multiple execution plan unravels after rulings Associated Press
08:23PM  Latest: Arkansas judge blocks state from using lethal drug Associated Press
08:15PM  Latest: Arkansas judge blocks state from using lethal drug Associated Press
Apr-13-17 06:17PM  Pfizer Says Execution Drugs Sold to Arkansas Without Knowing Bloomberg
Apr-12-17 05:05PM  McKesson's $157M Irving campus prescribes health for up to 2,500 workers American City Business Journals
Apr-07-17 03:15PM  Drug epidemic: 1 small-town mayor takes on pill distributors Associated Press
03:29AM  McKesson (MCK) Up 7.5% Since Earnings Report: Can It Continue? Zacks
Apr-06-17 06:16PM  [$$] Hammond Kennedy Whitney Sells GMD Distribution to McKesson The Wall Street Journal
01:27PM  3 Stocks for Warren Buffett Fans Motley Fool
Apr-05-17 10:27AM  McCormick Stock Higher on JPMorgan Upgrade TheStreet.com
Apr-04-17 08:15AM  McKesson Corp. breached its 50 day moving average in a Bearish Manner : MCK-US : April 4, 2017 Capital Cube
Apr-03-17 04:10PM  McKesson Completes Acquisition of CoverMyMeds Business Wire
Mar-31-17 12:19PM  McKesson Corp. : MCK-US: Dividend Analysis : March 01st, 2017 (record date) : By the numbers : March 31, 2017 Capital Cube
Mar-28-17 01:04PM  Walgreens Is Ready to Report Fiscal 2Q17 Earnings: What to Expect
Mar-24-17 01:54PM  The Threat And Risk Of Rising Interest Rates: Separating Fact From Fiction Insider Monkey
Mar-23-17 09:30AM  McKesson Corporation: Should Value Investors Pick this Stock? Zacks
Mar-22-17 08:09AM  McKesson Corp. breached its 50 day moving average in a Bearish Manner : MCK-US : March 22, 2017 Capital Cube
Mar-20-17 02:55PM  Is The Market Expensive? Buffett Says No Forbes
Mar-14-17 09:45AM  Lawsuit for Investors in shares of McKesson Corporation (NYSE: MCK) Against Directors Announced by Shareholders Foundation Accesswire
Mar-10-17 06:00AM  3 Profitable Healthcare Services Firms at Good Prices at Morningstar
Mar-07-17 11:17PM  Stocks: Ready for Trump rally rebound or third straight down day and bigger retreat from Dow 21K? at bizjournals.com
05:03PM  MCKESSON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Mar-02-17 05:59PM  Final Trade: WMT, DXJ & more
08:18AM  MCKESSON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAMMERGREN JOHN HChairman, President & CEOJun 01Sale164.9519,3093,185,0810Jun 01 06:35 PM
HAMMERGREN JOHN HChairman, President & CEOMay 31Sale162.5719,3103,139,17319,309Jun 01 06:35 PM
Lampert Erin MSVP & ControllerMay 31Sale160.66809129,97459Jun 01 05:59 PM
Lampert Erin MSVP & ControllerMay 30Sale160.5340464,854868May 31 06:37 PM
HAMMERGREN JOHN HChairman, President & CEOMay 30Sale162.3119,3163,135,09938,619May 31 06:31 PM
Lampert Erin MSVP & ControllerMay 27Option Exercise0.001,94402,003May 31 06:37 PM
HAMMERGREN JOHN HChairman, President & CEOMay 27Option Exercise0.0096,644096,644May 31 06:31 PM
JULIAN PAUL CEVP, Group PresidentMay 27Option Exercise0.0053,428053,485May 31 06:06 PM
Figueredo JorgeEVP, Human ResourcesMay 27Option Exercise0.0015,688023,661May 31 05:58 PM
BEER JAMES AEVP & Chief Financial OfficerMay 27Option Exercise0.0012,059027,539May 31 05:47 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerMay 27Option Exercise0.001,89801,898May 31 05:36 PM
Lampert Erin MSVP & ControllerMay 24Option Exercise0.0096096May 25 05:46 PM
HAMMERGREN JOHN HChairman, President & CEOMar 29Option Exercise67.8178,1105,296,63978,110Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 29Sale150.5678,11011,760,5380Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 28Option Exercise67.8122,3901,518,26622,390Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 28Sale150.0122,3903,358,7870Mar 30 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOMar 02Option Exercise67.8142,6002,888,70642,600Mar 03 04:36 PM
HAMMERGREN JOHN HChairman, President & CEOMar 02Sale150.4242,6006,407,9260Mar 03 04:36 PM
HAMMERGREN JOHN HChairman, President & CEOMar 01Option Exercise67.8157,9003,926,19957,900Mar 03 04:36 PM
HAMMERGREN JOHN HChairman, President & CEOMar 01Sale150.5557,9008,716,5960Mar 03 04:36 PM
BUDD WAYNE ADirectorDec 05Sale145.77723105,3920Dec 06 06:44 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerNov 30Buy144.52692100,0076,843Dec 01 06:58 PM
SALKA SUSAN RDirectorNov 02Buy136.351,000136,3512,005Nov 03 05:54 PM
McElligott Kathleen D.EVP, CIO & CTONov 01Option Exercise0.007830783Nov 02 06:49 PM
Lampert Erin MSVP & ControllerOct 31Sale123.99921114,1950Oct 31 05:48 PM
Lampert Erin MSVP & ControllerOct 29Option Exercise0.001,76501,765Oct 31 05:48 PM
BEER JAMES AEVP & Chief Financial OfficerOct 09Option Exercise0.006,416018,828Oct 11 06:04 PM
Lampert Erin MSVP & ControllerOct 03Sale165.941,739288,5700Oct 04 05:41 PM
HAMMERGREN JOHN HChairman, President & CEOSep 12Option Exercise67.81100,5006,814,905100,500Sep 13 05:42 PM
HAMMERGREN JOHN HChairman, President & CEOSep 12Sale180.77100,50018,166,9630Sep 13 05:42 PM
BUDD WAYNE ADirectorSep 12Sale179.702,309414,920723Sep 13 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOSep 06Option Exercise67.81100,5006,814,905100,500Sep 07 08:21 PM
HAMMERGREN JOHN HChairman, President & CEOSep 06Sale184.22100,50018,513,9390Sep 07 08:21 PM
JACOBS M CHRISTINEDirectorAug 22Sale193.78915177,3120Aug 23 07:02 PM
KNOWLES MARIE L/CADirectorAug 01Sale192.73915176,3480Aug 01 05:36 PM
BEER JAMES AEVP & Chief Financial OfficerJul 14Sale199.005,5001,094,50012,412Jul 15 04:50 PM